GlassScriptPhysician profile
William Mcallister
NPI 1821072646
$3,051.43
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,226 · 2020: $1,361 · 2021: $373 · 2022: $91.85.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,192.11 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $441.07 | 2019-2021 | |
| Pfizer INC. | $276.03 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $266.42 | 2019-2020 | |
| Abbvie INC. | $197.38 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $105.69 | 2019-2022 | |
| Bausch Health US, LLC | $98.65 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $79.37 | 2019 | |
| Janssen Pharmaceuticals, INC | $68.64 | 2019 | |
| Novo Nordisk INC | $54.76 | 2020-2021 | |
| Endo Pharmaceuticals INC. | $48.25 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.06 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $38.31 | 2019 | |
| Allergan, INC. | $36.06 | 2020 | |
| Merck Sharp & Dohme LLC | $35.51 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $21.51 | 2020 | |
| Lilly USA, LLC | $18.68 | 2019 | |
| Astellas Pharma US INC | $16.82 | 2020 | |
| Daiichi Sankyo INC. | $14.11 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mcallister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.